Martin Trott, MD
Otolaryngology · Jackson, WYNPI 1245339456
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 92.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $51,399 and has fallen 62.7% since, to $19,156 in 2025.
Across 141 payments — averaging $690.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$90K
- Intersect ENT, Inc.$3K
- Medtronic$2K
- Stryker$1K
- Medical Device Business Services, Inc.$884
- Acclarent, Inc$376
- plus $183 from 4 others
What the payments were for
- Consulting fees$57,66159%
- Speaking & faculty fees$13,80014%
- Travel & lodging$17,88418%
- Food & beverage$8,0208%
- Gifts$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 93 | $89,854 |
| Intersect ENT, Inc. | 7 | $2,765 |
| Medtronic | 19 | $1,842 |
| Stryker | 7 | $1,467 |
| Medical Device Business Services, Inc. | 2 | $884 |
| Acclarent, Inc | 5 | $376 |
| Regeneron Healthcare Solutions, Inc. | 5 | $95 |
| Optinose US, Inc. | 1 | $47 |
| Sanofi | 1 | $24 |
| KARL Storz Endoscopy-america | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$76,770
- Inspire Upper Airway Stimulation System$11,559
- PROPEL$2,765
- SINUVA$2,631
- SCOPIS ENT$1,348
- STEALTHSTATION S8 PLATFORM$807
- FUSION$486
- Relieva Spinplus$234
How this compares
Too few otolaryngology providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 37 | $1,002 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 16 | $312 |
| Mupirocin | 12 | $169 |
| Chlorhexidine Gluconate | 12 | $44 |
| Prednisone | 29 | $41 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Jackson
- Ryan BlackGillette$3K
- David NorcrossCasper$2K
- Caleb WilsonCasper$1K
- Brittany GreenbaumCasper$1K
- Scott BatemanSheridan$906
- Eugene PodrazikCasper$733
- David LiuRock Springs$374
- Melissa HertlerLander$314
- Thomas DavisGillette$232
- John RomanoCheyenne$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.